Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06156774 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

SARcopenia and Simplified Geriatric Assessment in Lymphoma Patients Undergoing CAR-T Cell Therapy: the FIL_SAR-CAR Project

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 8, 2025 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Site details revised at 3 of 21 sitesv5
  2. Site details revised at 6 of 21 sitesv4
  3. Site details revised at 11 of 21 sitesv3
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jan 2024 to Apr 18, 2024
    • Site details revised at 21 of 21 sites
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a multicenter prospective observational study lead by the FIL on sarcopenia and sGA as possible predictors of efficacy and toxicity outcomes in patients undergoing CAR-T cells treatment.
Trial Details
NCT Number NCT06156774
Lead Sponsor Fondazione Italiana Linfomi - ETS
Collaborators: Kite, A Gilead Company
Conditions
(from sponsor)		 Non-hodgkin Lymphoma,B Cell
Related terms Sarcopenia
Enrollment 130 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov